« SCT decides 8-1: FDA regulated medical devices products; FDA's new Risk Communication Advisory Committee | Main | Doctors Across New York Gets Some Play in CA Paper »

FEB. 26! Stem Cell Experts and NYS Lt. Gov. Paterson to participate in 3rd Annual Stem Cell Summit

See the Feb. 19 press release of RRY Publications announcing keynote speakers at the 3rd Annual Stem Cell Summit at the Hilton New York, NYC on Feb. 26. NYS Lt. Gov. Paterson has been a stem cell proponent and he will provide closing remarks.

The Summit will bring together institutional investors, industry participants and researchers with a complete update on the stem cell industry. Attendees will learn about the investment opportunities in the stem cell marketplace, the groundbreaking stem cell products physicians are using today and the growing market potential in terms of revenues.
(`1)

Among Lt. Gov Paterson's priorities read about "Funding Stem Cell Research" (2) an important priority where

...New York had stepped in where the federal government has faltered. Stem cell research will provide hope and innovation to New York...
Medical research is an area in which new hope and opportunity is found every day in New York State. New York's research institutions, teaching hospitals and pharmaceutical companies are world leaders in disease prevention. Thousands of New Yorkers work tirelessly each day in the search for new cures and medicines. However, that critical progress has been hindered by Washington’s refusal to fund stem cell research.

... Over the next decade, $600 million in state funds will go to stem cell research. ...As we continue to innovate in the area of medical research, lives will be saved and new sectors of our economy will be born. Stem cell research offers New York profound economic opportunities and this funding commitment by the state will help position New York as a world leader in the field.

Already NYSTEM's work has resulted in important grant awards.

On January 7, 2008, the Funding Committee of the Empire State Stem Cell Board voted to authorize the Department of Health to proceed with the negotiation of a "Merit Peer Review" contract with the successful bidder, the American Institute of Biological Sciences (AIBS). The anticipated start date for this five-year contract is April 1, 2008.
On January 7, 2008, the Funding Committee also voted to award a total of $14.5 million to support stem cell research and training at 25 institutions that responded to a Request for Applications issued on November 14, 2007. The one-year institutional development awards were designed to increase the capacity of New York State research institutions to engage in stem cell research. Together these awards provide $6.1 million for direct stem cell research, $7.4 million for stem cell research infrastructure, and $1 million for stem cell research training.
(3)

The Summit agenda itself reveals how exciting the latest developments in stem cell research related to therapeutic areas are. Therapeutic areas to be presented on are: cardiovascular, autoimmune and anti-inflammatory, hematology and oncology musculoskeletal, neurology and nerve repair and regeneration . Over 32 participants in the stem cell research field will speak at this particular Summit. The field of stem cell related therapeutic research is building momentum each month with new developments and discoveries.
It will be an impressive day for all who attend. Registration is permitted at the door. (4)

(1) press release http://www.stemcellsummit.com/news-releases/02-19-08.pdf
(2) http://www.ny.gov/governor/press/lt_stemcell.html
(3) http://stemcell.ny.gov/research_support_grants_awards.html
(4) http://www.stemcellsummit.com/2008/agenda08.html

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

This page contains a single entry from the blog posted on February 24, 2008 4:47 PM.

The previous post in this blog was SCT decides 8-1: FDA regulated medical devices products; FDA's new Risk Communication Advisory Committee .

The next post in this blog is Doctors Across New York Gets Some Play in CA Paper.

Many more can be found on the main index page or by looking through the archives.